Why Targeted DNA + RNA Single-Cell Analysis?

By integrating targeted DNA genotyping with RNA expression profiling, you can confidently pinpoint disease-driving variants, uncover resistance mechanisms, and characterize engineered cell populations — all from the same cells.

Refine Disease Classification and Mechanistic Insight

Combine somatic mutation and expression profiles to distinguish subclones, identify driver mutations, and reveal dysregulated pathways driving disease progression.

Accelerate Biomarker and Drug Target Discovery

Link genomic variants to functional RNA readouts to confirm target expression, uncover actionable biomarkers, and validate therapeutic mechanisms.

Advance Cell and Gene Therapy Characterization

Correlate gene editing outcomes and vector copy number with transcriptional changes to verify on-target activity, assess efficacy, and ensure functional validation.

Applications

Oncology

Tumor Classification & Clonal Subtyping

  • Combining somatic mutation profiles (DNA) with transcriptional signatures (RNA) allows more precise stratification of cancers

Identifying Driver Mutations & Pathway Dysregulation

  • DNA reveals recurrent driver mutations, and RNA shows their influence on regulatory pathways

Predicting Therapy Response

  • RNA analysis can reveal alternative splicing, pathway rewiring, or activation of bypass signaling

Target Discovery & Rare Disease

Drug Target Discovery & Biomarker Development

  • DNA detects mutations targetable by drugs and RNA validates that the gene is actually expressed, contributing to the disease state

Rare Genetic & Inherited Disorders

  • Many rare disorders arise from post-zygotic DNA mutations present in only a subset of cells. Multi-omics can connect the DNA mutation to aberrant RNA signatures.

Therapy Response & Mechanism of Action

  • RNA profiling can reveal whether a therapy achieves its intended effects by monitoring upregulation or inhibition of target genes, providing a direct readout of functional impact.

RNA Panels

Ready-to-Ship

Tapestri Single-cell RNA Catalog Panel

Predesigned and ready-to-ship RNA panels. Wet lab-tested to assure performance.

Build-to-Order

Tapestri Single Cell Targeted RNA Custom Add on Panel

Fully customizable RNA panels for maximum flexibility. Easily order a custom panel by contacting us.

Order a predesigned RNA panel or create a custom panel with your own targets (up to 1,000 genes)

Select panel content relevant to your specific sequencing applications to understand gene expression profiles and changes. We currently offer a catalog targeted panel covering key immune cell types and cell state markers based on public databases and actionable clinical targets.


Workflow

Tapestri Single-Cell DNA + RNA Workflow

Sanity Image

Translate Insight Into Action With Fully Interpreted Results

This experiment highlights the power of the Tapestri® platform to distinguish cell types based on both genotype and gene expression profiles. A monocyte-like cell line (THP-1) was initially mixed with a 10% spike-in of the breast cancer cell line T47D and analyzed on Tapestri® to establish a baseline gene expression profile.

Next, the THP-1 cells were stimulated with lipopolysaccharide (LPS) and again mixed with a 10% spike-in of untreated T47D cells before being run on Tapestri®.

Because the genotypic profiles of the two cell lines remain distinct, genotype-based demultiplexing enables clear identification of each population. Within the THP-1 population, however, LPS treatment induces a measurable shift in gene expression, while the T47D spike-in remains transcriptionally unchanged.

These transcriptional changes in the treated THP-1 cells are evident in both the heatmap (Figure 1) and the UMAP projection (Figure 2) below.

Sanity Image
Figure 1: The left side of the heat map shows the distinct genotype profile for THP-1 before and after treatment with LPS, no change in genotype is expected and seen. The changes in gene expression when THP-1 is treated with LPS are shown on the right side of the heatmap.
Sanity Image
Figure 2: The UMAP in the bottom right quadrant of each panel shows the cell mix of 90% THP-1 and 10% T47D distinguished by genotype. While the remaining 3 quadrants show the difference in expression for the noted genes before (left) and after (right) THP-1 was treated with LPS.

Bioinformatics Solution

Get more from your data with Tapestri Clonal Insights now updated for DNA + RNA analysis.

Tapestri Clonal Insights DNA + RNA is a fully automated solution that integrates secondary and tertiary analysis to detect known and de novo variants, immunophenotype signatures, and gene expression.

Key features:

  • Genotype-based sample demultiplexing (up to 3)
  • Gene expression profiling
  • Known and de novo variant calling
  • Clone and phylogeny construction
  • Detailed clone reports: variant lists and protein signatures
  • Multi-timepoint analysis with fish plots and side-by-side clone metrics

Get one comprehensive report with clonal summaries with detailed gene expression profiles, variant calls and protein signatures, phylogeny, and longitudinal clone evolution.


Get Started

Contact us to begin your evaluation

Request quote